Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Filings indexed 605 across all filing types
Latest filing 2022-05-16 Director's Dealing
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY DIRECTOR
Director's Dealing Classification · 100% confidence The document is a voluntary announcement by Kindstar Globalgene Technology, Inc. regarding an increase in shareholding by a director, Dr. Huang Shiang. It details the purchase of shares by the director, the resulting shareholding percentage, and compliance with legal requirements. There is no financial report, earnings data, or meeting materials. The content fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives. The document length is short and focused solely on this shareholding change, confirming it is not a full financial report or announcement of a report publication.
2022-05-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data. The content fits the category of Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares.
2022-05-13 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about transactions in own shares (share buybacks). Therefore, it fits the category 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2022-05-12 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in issued share capital, not on financial results, management commentary, or other report types. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 10,000 characters and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-05-11 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and disclosures required by the exchange rules. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document is not an announcement of a report, nor is it a full financial report or management discussion. Therefore, the appropriate classification is 'POS' for Transaction in Own Shares.
2022-05-10 English
Next Day Disclosure Returns - Changes in issued share capital and/or share buyback
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed data on repurchases of shares, cancellations, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and capital changes rather than financial results, management changes, or legal matters. The document length is about 10,898 characters, which is substantive and contains detailed transactional data. This matches the definition of a 'Transaction in Own Shares' filing, which reports on the company's buyback or sale of its own shares.
2022-05-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.